Covidence vs Sysrev
Covidence scores 4.1 to Sysrev's 4.0 among the systematic review platforms we rate, and is the better pick for 1 of the 5 kinds of buyer below.
Covidence wins, 4.1 to 4.0
Sysrev searches PubMed and OpenAlex directly inside the app; Covidence only imports references you already found elsewhere, through EndNote or Zotero, for instance. Covidence answers back with automatic reference deduplication, an auto-generated PRISMA flow diagram, and a risk of bias assessment built into every review, none of which Sysrev offers. Sysrev's cheapest paid plan is $50 a month per member and includes a documented API on its Premium and Enterprise tiers; Covidence costs $339 a year with unlimited collaborators included but no API at all.
Pick Covidence if you need automatic deduplication, PRISMA and risk of bias built in.
Pick Sysrev if you want to search PubMed and OpenAlex without importing first.
Best for
Who each one suits, decided on the criteria that matter to that buyer and the checked facts where the two differ.
- Searches a database of papers: Sysrev yes, Covidence no
- Removes duplicate references: Covidence yes, Sysrev no
- PRISMA flow diagram: Covidence yes, Sysrev no
- Risk of bias assessment: Covidence yes, Sysrev no
- Export formats: Covidence RIS, CSV, PubMedXML, Sysrev EndNote XML, Excel, Parquet
- Works with Zotero, Mendeley, EndNote and others: EndNote, Zotero, RefWorks, Mendeley, RevMan, CRS against EndNote, Zotero
- Does not train AI on your data: Covidence yes, Sysrev does not say
How they score
Both are scored the same way, against the other systematic review platforms we rate, from facts on each vendor's own pages. Covidence leads on 3 of 6 criteria.
Where they differ
Every point where the two vendors' published facts disagree, with a link to where each fact was read. "Not published" means the vendor does not say either way.
Published by only one of them
Where they match (19)
Pricing, plan by plan
Every plan each vendor publishes, monthly and yearly where both are offered.
Covidence
Sysrev
Pros and cons
From each tool's full review, written from the same checked facts.
Covidence
- Purpose-built for systematic reviews and evidence synthesis, making it highly optimized for that specific academic and clinical workflow.
- Supports unlimited collaborators on every plan, enabling large research teams to work together without user-count penalties.
- Title and abstract screening interface is fast and well-designed, reducing friction in the most time-consuming part of the review process.
- Mobile browser screening is supported, allowing co-reviewers to contribute while traveling or away from their desks.
- Trusted by over 536,000 researchers and students across more than 480 universities and hospitals, indicating strong real-world validation.
- Supports multiple import formats including RIS, CSV, and PubMedXML, making it compatible with major reference databases like PubMed.
- Conflict resolution tools are built into the screening workflow, helping teams manage disagreements systematically and according to protocol.
- No native search functionality — users must import references from external databases before any work can begin in the platform.
- AI features do not meet modern expectations, which may disappoint researchers looking for intelligent automation or AI-assisted synthesis.
- Solo reviewer pricing starts at $339 per year, which is a significant cost for individual academics or students without institutional backing.
- The tool is not useful outside of systematic review workflows, making it a poor fit for general-purpose research or literature exploration.
- Pricing and product design clearly favor institutional users, meaning solo or small-team reviewers may feel like second-class customers.
- Relies on external tools like RevMan for final output, so it does not offer an end-to-end standalone solution for evidence synthesis.
Sysrev
- Supports a wider range of input formats than most competitors, including PDFs, title-abstract pairs, plain text, and structured JSON.
- The AI Auto Labeler automates document labeling, reducing manual workload for large document sets.
- Human-in-the-loop review structure allows teams to verify and correct AI-flagged labels before finalizing.
- Multi-phase project setup allows outputs from one project to feed directly into the next, supporting complex review workflows.
- Multiple reviewers can collaborate on the same project simultaneously, enabling team-based systematic reviews.
- Supports structured data extraction including Boolean fields, categorical labels, string extraction, and tabular data.
- Has been operational since 2017, suggesting a degree of platform maturity and stability for academic use cases.
- No general web search, though PubMed and OpenAlex search are built in, for other sources, users must supply their own documents.
- Almost no presence on major third-party review platforms like G2, Capterra, or Trustpilot, making independent validation difficult.
- The scope is narrower than the homepage suggests, as it is not a general-purpose AI research assistant.
- Primarily suited to academic, scientific, and regulatory use cases, limiting its appeal for broader research workflows.
- The lack of community discussion and public reviews makes it hard to assess real-world reliability and support quality.
Covidence vs Sysrev: common questions
Which is better, Covidence or Sysrev?
Covidence scores 4.1 and Sysrev 4.0 out of 10 among the systematic review platforms we rate. Covidence is ahead on systematic reviews, pricing and citing and writing. Sysrev is ahead on finding papers and access, teams and privacy.
Is Covidence or Sysrev cheaper?
Covidence's cheapest paid plan is $339/year and Sysrev's is $50/mo. Compare what each plan includes below before going on price alone.
What can Covidence do that Sysrev cannot?
On the facts both vendors publish: removes duplicate references, pRISMA flow diagram and risk of bias assessment.
What can Sysrev do that Covidence cannot?
On the facts both vendors publish: searches a database of papers and aPI.
